Instrument Inactif

Communiqués Endocyte, Inc.

Actions

US29269A1025

Recherche biotechnologique et médicale

Communiqués

20/12/18	Endocyte Stockholders Approve Merger Agreement with Novartis AG	GL
07/11/18	Endocyte Provides Third Quarter 2018 Financial Results and Operational Update	GL
18/10/18	Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion	GL
03/10/18	Endocyte becomes first Purdue startup to reach $1.5B in value	GL
27/09/18	Endocyte to Present at Two Investor Conferences on October 2nd	GL
10/09/18	Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)	GL
29/08/18	Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference	GL
28/08/18	UPDATE - Endocyte Announces Presentations at the CAR-TCR Summit 2018	GL
28/08/18	UPDATED: Endocyte Announces Presentations at the CAR-TCR Summit 2018	PU
28/08/18	Endocyte Announces Presentations at the CAR-TCR Summit 2018	GL
17/08/18	Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition	GL
08/08/18	Endocyte to Present at the 2018 Wedbush PacGrow Healthcare Conference	GL
31/07/18	Endocyte Provides Second Quarter 2018 Financial Results and Operational Update	GL
25/07/18	Endocyte : Announces Second Quarter 2018 Financial Results and Operational Update Call	PU
25/07/18	Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call	GL
09/07/18	Endocyte : and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177	PU
09/07/18	Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177	GL
25/06/18	Endocyte to Join the Russell 3000® Index	GL
22/06/18	Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting	GL
17/05/18	Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting	GL
09/05/18	Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617	GL
09/05/18	Endocyte Provides First Quarter 2018 Financial Results and Operational Update	GL
02/05/18	Endocyte Announces First Quarter 2018 Earnings Call	GL
01/05/18	Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference	GL
16/04/18	Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018	GL